Search Results

CK-636 50mg 50mg  | Purity Not Available

Adooq Bioscience

CK-636 is a Arp2/3 complex inhibitor. CK-636 binds between Arp2 and Arp3, where it appears to block movement of Arp2 and Arp3 into their active conformation.

More Information Supplier Page

CK-636 25mg 25mg  | Purity Not Available

Adooq Bioscience

CK-636 is a Arp2/3 complex inhibitor. CK-636 binds between Arp2 and Arp3, where it appears to block movement of Arp2 and Arp3 into their active conformation.

More Information Supplier Page

CK-636 10mM * 1mL in DMSO 10mM * 1mL in DMSO  | Purity Not Available

Adooq Bioscience

CK-636 is a Arp2/3 complex inhibitor. CK-636 binds between Arp2 and Arp3, where it appears to block movement of Arp2 and Arp3 into their active conformation.

More Information Supplier Page

CK-636 100mg 100mg  | Purity Not Available

Adooq Bioscience

CK-636 is a Arp2/3 complex inhibitor. CK-636 binds between Arp2 and Arp3, where it appears to block movement of Arp2 and Arp3 into their active conformation.

More Information Supplier Page

CK-636 10mg 10mg  | Purity Not Available

Adooq Bioscience

CK-636 is a Arp2/3 complex inhibitor. CK-636 binds between Arp2 and Arp3, where it appears to block movement of Arp2 and Arp3 into their active conformation.

More Information Supplier Page

PTC-209 5mg 5mg  | Purity Not Available

Adooq Bioscience

PTC-209 is a novel potent and selective BMI-1 inhibitor, targeting the BMI-1 self-renewal machinery with an IC50 of ~0.5 ?M.

More Information Supplier Page

PTC-209 25mg 25mg  | Purity Not Available

Adooq Bioscience

PTC-209 is a novel potent and selective BMI-1 inhibitor, targeting the BMI-1 self-renewal machinery with an IC50 of ~0.5 ?M.

More Information Supplier Page

PTC-209 10mM * 1mL in DMSO 10mM * 1mL in DMSO  | Purity Not Available

Adooq Bioscience

PTC-209 is a novel potent and selective BMI-1 inhibitor, targeting the BMI-1 self-renewal machinery with an IC50 of ~0.5 ?M.

More Information Supplier Page

PTC-209 10mg 10mg  | Purity Not Available

Adooq Bioscience

PTC-209 is a novel potent and selective BMI-1 inhibitor, targeting the BMI-1 self-renewal machinery with an IC50 of ~0.5 ?M.

More Information Supplier Page